Literature DB >> 15639644

Pristane-induced autoimmunity in germ-free mice.

Akiei Mizutani1, Victoria M Shaheen, Hideo Yoshida, Jun Akaogi, Yoshiki Kuroda, Dina C Nacionales, Yoshioki Yamasaki, Michito Hirakata, Nobutaka Ono, Westley H Reeves, Minoru Satoh.   

Abstract

Hypergammaglobulinemia and autoantibodies are reduced in pristane-treated specific pathogen-free mice vs. conventionally housed controls, consistent with the role of microbial stimulation in this model. To determine whether microbial stimulation is required, BALB/c mice housed under germ-free conditions were treated i.p. with sterile PBS or pristane and examined 6 months later. As in conventional mice, pristane-treated germ-free mice developed peritoneal granulomas and hypergammaglobulinemia with increased IgG2a/IgG1 ratios. LPS stimulation induced more IL-6, IL-12, and TNF-alpha, and anti-CD3 induced more IFN-gamma and IL-4 by peritoneal cells from pristane-treated mice vs. control. Anti-nRNP/Sm and -Su autoantibodies were found in 40% and 43%, respectively, of pristane-treated germ-free mice by immunoprecipitation. Thus, bacterial stimulation was not required for lupus autoantibodies, peritoneal granuloma formation, hypergammaglobulinemia, or cytokine overproduction. Although microbial stimulation acts synergistically with pristane, these results clearly indicate that pristane does not act merely by increasing exposure to microbial products such as LPS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639644     DOI: 10.1016/j.clim.2004.09.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

Review 2.  Diet, microbiota and autoimmune diseases.

Authors:  S M Vieira; O E Pagovich; M A Kriegel
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

3.  Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.

Authors:  Haoyang Zhuang; Shuhong Han; Yuan Xu; Yi Li; Hai Wang; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

Review 4.  Pristane-induced lupus: considerations on this experimental model.

Authors:  Eduarda Correa Freitas; Mayara Souza de Oliveira; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2017-09-06       Impact factor: 2.980

Review 5.  How the microbiota shapes rheumatic diseases.

Authors:  Tom Van de Wiele; Jens T Van Praet; Massimo Marzorati; Michael B Drennan; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2016-06-16       Impact factor: 20.543

Review 6.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

Review 7.  Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.

Authors:  Westley H Reeves; Pui Y Lee; Jason S Weinstein; Minoru Satoh; Li Lu
Journal:  Trends Immunol       Date:  2009-08-19       Impact factor: 16.687

Review 8.  Why can't we find a new treatment for SLE?

Authors:  Robert Eisenberg
Journal:  J Autoimmun       Date:  2009-03-28       Impact factor: 7.094

Review 9.  Animal Models of Interferon Signature Positive Lupus.

Authors:  Haoyang Zhuang; Christopher Szeto; Shuhong Han; Lijun Yang; Westley H Reeves
Journal:  Front Immunol       Date:  2015-06-05       Impact factor: 7.561

10.  Maintenance of autoantibody production in pristane-induced murine lupus.

Authors:  Shuhong Han; Haoyang Zhuang; Yuan Xu; Pui Lee; Yi Li; Joseph C Wilson; Osvaldo Vidal; Hong Seok Choi; Yu Sun; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Res Ther       Date:  2015-12-30       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.